Dual Therapeutic Targeting of Lung Infection and Carcinoma Using Lactoferrin-Based Green Nanomedicine.

In view of the promising applications of nanoparticles in drug delivery, this study highlights the fabrication of new bioactive green protein-polysaccharide nanocomplexes with significant antibacterial and antitumor efficacies. We preformulated the water-insoluble drugs Quercetin (Quer) and Resveratrol (Res) as water-soluble nanocrystals to facilitate their entrapment in the electrostatic lactoferrin-chondroitin (Lf-ChS) nanocomplex. Quer and Res were physically entrapped in the Lf-ChS nanomatrix with high encapsulation efficiencies (EE %) of 85.2 and 90.1% w/w for Quer and Res, respectively. The in vitro synergetic antibacterial effects of the studied compounds against all bacterial strains were confirmed. Res-Quer Lf-ChS NPs revealed an enhanced cytotoxic effect against A549 lung cancer cells. A new model of polymicrobial lung infection was designed, where treatment with Res-Quer Lf-ChS NPs (233.5 ± 6.59 nm) resulted in a marked decline of 3.2 log units in bacterial counts. In the lung tumor model, the potent antitumor efficacy of the developed Res-Quer Lf-ChS NPs was demonstrated by a noticeable decline in both lung weight and the biomarkers compared to the positive control group that did not receive any treatment. In conclusion, the green Res-Quer Lf-ChS NPs possess antibacterial and antitumor attributes for potential lung infection and tumor therapy.